Publications

5600 Results

Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the Adjuvant Colon Cancer Endpoints Database

Authors
WY Cheung;LA Renfro;D Kerr;A de Gramont;LB Saltz;A Grothey;SR Alberts;T Andre;KA Guthrie;R LaBianca;G Francini;J-F Seitz;C O'Callaghan;C Twelves;E Van Cutsem;DG Haller;G Yothers;DJ Sargent
Journal / Conference
Journal of Clinical Oncology, Apr 10;34(11):1182-1189
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID26858337
PMC
PMC4933130
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Authors
AM Lee;Q Shi Qian;SR Alberts;DJ Sargent;FA Sinicrope;JL Berenberg;A Grothey;B Polite;E Chan;S Gill;MS Kahlenberg;SG Nair;AF Shields;RM Goldberg;RB Diasio
Journal / Conference
Pharmacogenetics and Genomics, Mar;26(3):133-137
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID26658227
PMC
PMC4738010
Study Number(s)
CTSU/N0147

A phase III randomized trial comparing FDA approved standard of care adjuvant therapy to one year of pembrolizumab in patients with high risk resected melanoma SWOG 1404

Authors
K Grossmann;V Sondak;M Othus;A Tarhini;S Patel;J Kirkwood;A Ribas;J Moon
Journal / Conference
American Association for Cancer Research Annual Meeting (2016, April 16-20, New Orleans, LA), poster session, abst #CT125
Year
2016
Research Committee(s)
Melanoma
Study Number(s)
S1404

Bone biomarkers and overall survival (OS) in men with castration resistant prostate cancer (CRPC) and skeletal metastases: updated results from SWOG 0421, a phase III trial of docetaxel +/- atrasentan

Authors
PN Lara;M Plets;C Tangen;E Gertz;N Vogelzang;D Quinn;I Thompson;M van Loan
Journal / Conference
Annals of Oncology vol. 27, 2016 Supp 6, abst. 754P; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), poster
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
S0421

A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate risk

Authors
R Travis;P Appleby;RM Martin;JMP Holly;D Albanes;A Black;HB Bueno-de-Mesquita;JM Chan;C Chen;MD Chirlaque;MB Cook;M Deschasaux;JL Donovan;L Ferrucci;P Galan;G Giles;E Giovannucci;M Gunter;LA Habel;FC Hamdy;K Helzlsouer;S Hercberg;RN Hoover;J Janssen;R Kaaks;T Kubo;T Kubo;L Le Marchand;EJ Metter;K Mikami;JK Morris;D Neal;M Neuhouser;K Ozasa;D Palli;M Pollak;E Platz;AJ Price;MJ Roobol;C Schaefer;J Schenk;G Severi;M Stampfer;P Stattin;A Tamakoshi;C Tangen;M Touvier;NJ Wald;N Weiss;R Ziegler;TJ Key;NE Allen
Journal / Conference
Cancer Research Apr 15;76(8):2288-2300; 2016 Feb 26 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID26921328
PMC
PMC4873385
Study Number(s)
SWOG-9217

Blood-Based Biomarkers in Patients (pts) with Metastatic Colorectal Cancer (mCRC) Treated with FOLFOX or FOLFIRI + Bevacizumab (Bev), Cetuximab (Cetux), or Bev + Cetux: Results from CALGB 80405 (Alliance)

Authors
AB Nixon;AB Sibley;AJ Hatch;Y Liu;C Jiang;F Mulkey;MD Starr;JC Brady;D Niedzwiecki;F Innocenti;A Venook;H Hochster;H Lenz;B O'Neil;K Owzar;H Hurwitz
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 3597); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), poster session
Year
2016
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

Authors
A Gusev;H Shi;G Kichaev;M Pomerantz;F Li;WH Long;SA Ingles;RA Kittles;S Strom;S Strom;B Rybicki;B Nemesure;WB Isaacs;W Zheng;C Pettaway;E Yeboah;Y Tettey;R Biritwum;A Adjei;E Tay;L Truelove;S Niwa;A Chokkalingam;E John;AB Murphy;L Signorello;J Carpten;M Leske;S-Y Wu;A Hennis;C Neslund-Dudas;A Hsing;L Chu;P Goodman;E Klein;J Witte;G Casey;S Kaggwa;MB Cook;D Stram;J Blot;RA Eeles;D Easton;ZS Kote-Jarai;AA Al Olama;S Benlloch;K Muir;GG Giles;MC Southey;LM Fitzgerald;H Gronberg;F Wiklund;M Aly;B Henderson;J Schleutker;T Wahlfors;TL Tammela;B Nordestgaard;TJ Key;RC Travis;DE Neal;JL Donovan;FC Hamdy;P Pharoah;N Pashayan;K Khaw;JL Stanford;S Thidbodeau;S McDonnell;D Schaid;C Maier;W Vogel;M Luedeke;K Herkommer;A Kibel;C Cybulski;D Wokolorczyk;W Kluzniak;L Cannon-Albright;C Teerlink;H Brenner;A Dieffenbach;V Arndt;JY Park;TA Sellers;H Lin;C Slavov;R Kaneva;V Mitev;J Batra;A Spurdle;JA Clements;M Teixeira;H Pandha;A Michael;P Paula;S Maia;A Kierzek;DV Conti
Journal / Conference
Nature Communications 2016 Apr 7;7:10979. doi: 10.1038/ncomms10979
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27052111
PMC
PMC4829663
Study Number(s)
S0000

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

Authors
M Zhang;Z Wang;O Obazee;J Jia;E Childs;J Hoskins;G Figlioli;E Mocci;I Collins;CC Chung;C Hautman;A Arslan;L Beane-Freeman;P Bracci;J Buring;EJ Duell;S Gallinger;GG Giles;GE Goodman;P Goodman;A Kamineni;L Kolonel;MH Kulke;N Malats;S Olson;H Sesso;K Visvanathan;E White;W Zheng;CC Abnet;G Andreotti;M Austin;H Bueno-de-Mesquita;D Basso;M Boutron-Ruault;M Bijlsma;H Brenner;L Burdette;D Campa;N Caporaso;G Capurso;G Cavestro;C Cotterchio;E Costello;J Elena;U Boggi;J Gaziano;EL Giovannucci;M Goggins;M Gorman;M Grosse;C Haiman;M Hassan;K Helzlsouer;N Hu;D Hunter;EIskierka-Jazdzewska;M Jenab;R Kaaks;T Key;K Khaw;EA Klein;M Kogevinas;V Krogh;J Kupcinskas;R Kurtz;M Landi;S Landi;L Le Marchand;A Mambrini;S Mannisto;R Milne;R Neale;A Oberg;S Panico;A Patel;P Peeters;U Peters;R Pezzilli;F Tavano;M Porta;M Purdue;J Quiros;E Riboli;N Rothman;A Scarpa;G Scelo;X Shu;D Silverman;P Soucek;O Strobel;M Sund;E Malecka-Panas;P Taylor;R Travis;M Thornquist;A Tjonneland;J Tobias;D Trichopoulos
Journal / Conference
Oncotarget 2016 Oct 11;7(41):66328-66343; 2016 Aug 1[Epub ahead of print]
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27579533
PMC
PMC5340084
Study Number(s)
S0000

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL): a sub-analysis of SWOG S0816 phase 2 trial

Authors
A Danilov;H Li;O Press;I Shapira;L Swinnen;A Noy;E Reid;S Smith;J Friedberg
Journal / Conference
Leukemia & Lymphoma Feb;58(2):461-465; 2016 Jul 7:1-5. [Epub ahead of print] [print in 2017]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27386786
PMC
PMC5130311
Study Number(s)
S0816

Integrating traditional Electronic Data Capture (EDC) with new systems

Authors
C Cook;T Phillips;M Leblanc
Journal / Conference
Society for Clinical Trials (May 15-18, 2016, Montreal,Quebec, Canada), poster
Year
2016
Research Committee(s)
Lung and Melanoma
Study Number(s)
S1400, S1404